INFLAMMATORY DISEASE
Clinical trials for INFLAMMATORY DISEASE explained in plain language.
Never miss a new study
Get alerted when new INFLAMMATORY DISEASE trials appear
Sign up with your email to follow new studies for INFLAMMATORY DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Shingles shot showdown: which vaccine works best for RA patients?
⭐️ VACCINE ⭐️ CompletedThis study looked at two shingles vaccines, Zostavax and Shingrix, in 154 adults with rheumatoid arthritis who were taking the drug abatacept. The goal was to see how well the vaccines boosted immunity and whether they were safe. Researchers measured immune responses before vacci…
Matched conditions: INFLAMMATORY DISEASE
Phase: PHASE2 • Sponsor: Kevin Winthrop • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 00:31 UTC
-
New imaging tracer aims to spot hidden infections
Diagnosis CompletedThis study tested a radioactive tracer called 11C-PABA to see if it can help doctors find infections deep inside the body using PET scans. 13 healthy people and patients with infections, inflammation, or cancer took part. The goal was to see if this imaging method can tell infect…
Matched conditions: INFLAMMATORY DISEASE
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated May 11, 2026 20:39 UTC
-
New PET tracer may light up hidden infections
Knowledge-focused CompletedThis study tested a new radioactive tracer called 18F-FDS in 16 people with infections or cancer. The goal was to see if the tracer can specifically highlight areas of Gram-negative bacterial or invasive mold infections on PET scans. Researchers measured where the tracer went in …
Matched conditions: INFLAMMATORY DISEASE
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated May 11, 2026 20:46 UTC
-
Scientists engineer 'smarter' IL-2 to tame overactive immune systems
Knowledge-focused CompletedThis study tested specially engineered versions of a natural immune protein (IL-2) in blood samples from 67 people with autoimmune or inflammatory diseases like lupus, multiple sclerosis, and rheumatoid arthritis. The goal was to see if these modified proteins could selectively a…
Matched conditions: INFLAMMATORY DISEASE
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Apr 24, 2026 16:18 UTC